Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BYON4228 |
Trade Name | |
Synonyms | BYON-4228|BYON 4228 |
Drug Descriptions |
BYON4228 is a monoclonal antibody that targets SIRPA, including polymorphic variants of SIRPA, and prevents its interaction with CD47, which potentially enhances macrophage and neutrophil-dependent tumor cell killing (PMID: 37068796). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BYON4228 | BYON4228 | 0 | 0 |
BYON4228 + Rituximab | BYON4228 Rituximab | 0 | 1 |